LRRC15 and neoplasm: It further identifies PLXDC1+ PSCs near aggressive LRRC15+ cancer‐associated myofibroblasts and SPP1+ macrophages, forming a desmoplastic and immunosuppressive tumor niche that promotes CD8+ T cell exhaustion, contributing to poor immunotherapy outcomes in pancreatic cancer.